Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/35305

Registo completo
Campo DCValorIdioma
dc.contributor.authorLoureiro, Ana Isabel Sápor
dc.contributor.authorBernardes, Gonçalo J. L.por
dc.contributor.authorShimanovich, Ulyanapor
dc.contributor.authorSárria, M. P.por
dc.contributor.authorNogueira, Eugéniapor
dc.contributor.authorPreto, Anapor
dc.contributor.authorGomes, Andreia Cpor
dc.contributor.authorPaulo, Artur Cavacopor
dc.date.accessioned2015-05-27T11:22:44Z-
dc.date.available2015-05-27T11:22:44Z-
dc.date.issued2015-07-
dc.date.submitted2015-01-
dc.identifier.citationLoureiro, Ana; Bernardes, Gonçalo J. L.; Shimanovich, Ulyana; Sárria, M. P.; Nogueira, Eugénia; Preto, Ana; Gomes, Andreia C.; Paulo, Artur Cavaco, Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors. Nanomedicine: Nanotechnology, Biology, and Medicine, 11(5), 1077-1083, 2015por
dc.identifier.issn1549-9634por
dc.identifier.urihttps://hdl.handle.net/1822/35305-
dc.description.abstractFolic Acid (FA)-tagged protein nanoemulsions were found to be preferentially internalized on B-cell lymphoma cell line (A20 cell line), which, for the first time, are reported to express folate receptor (FR)-alpha. Carbon monoxide releasing molecule-2 (CORM-2) was incorporated in the oil phase of the initial formulation. FA-functionalized nanoemulsions loaded with CORM-2 exhibited a considerable antitumor effect and an increased survival of BALB/c mice bearing subcutaneous A20 lymphoma tumors. The developed nanoemulsions also demonstrated to be well tolerated by these immunocompetent mice. Thus, the results obtained in this study demonstrate that FA-tagged protein nanoemulsions can be successfully used in cancer therapy, with the important ability to delivery drugs intracellularly.por
dc.description.sponsorshipSFRH/BD/81479/2011 and SFRH/BD/81269/2011 scholarships from Fundação para a Ciência e a Tecnologia (FCT). This work has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement NMP4-LA-2009-228827 NANOFOL. This work was supported by FEDER through POFC-COMPETE and by Portuguese funds from FCT through the project PEst-OE/BIA/UI4050/2014.por
dc.language.isoengpor
dc.publisherElsevier B.V.por
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/228827/EU-
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FBIA%2FUI4050%2F2014/PT-
dc.rightsopenAccesspor
dc.subjectProtein nanoemulsionspor
dc.subjectFolic acidpor
dc.subjectCORM-2por
dc.subjectSpecific uptakepor
dc.subjectTargeted drug deliverypor
dc.titleFolic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumorspor
dc.typearticle-
dc.peerreviewedyespor
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S1549963415000726por
dc.commentsCEB19878por
sdum.publicationstatuspublishedpor
oaire.citationStartPage1077por
oaire.citationEndPage1083por
oaire.citationIssue5por
oaire.citationConferencePlaceNetherlands-
oaire.citationTitleNanomedicine: Nanotechnology, Biology and Medicinepor
oaire.citationVolume11por
dc.date.updated2015-05-27T06:38:04Z-
dc.identifier.eissn1549-9642-
dc.identifier.doi10.1016/j.nano.2015.02.022por
dc.identifier.pmid25791804por
dc.subject.fosCiências Médicas::Biotecnologia Médicapor
dc.subject.wosScience & Technologypor
sdum.journalNanomedicine: Nanotechnology, Biology, and Medicinepor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series
CBMA - Artigos/Papers
DBio - Artigos/Papers

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_19878_1.pdf683,83 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID